CDKN1A and prostate cancer: PFE can cause G1-phase arrest of prostate cancer PC3 cell through dwindling the expressions of cyclins D and E and increasing the levels of cyclin-dependent kinase-2, -4 and -6, and thus resulting in an increase in WAF1/p21 as well as KIP1/p27[13].